Alyeska Investment Group
KZIA

Alyeska Investment Group’s Kazia Therapeutics KZIA Stock Holding History

Alyeska Investment Group’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-738,321
Closed -$5.09M – 688
2025
Q4 		$5.09M Buy
+738,321
New +$6.29M 0.01% 456

Other funds holding KZIA

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Alyeska Investment Group's KZIA Position: Q1 2026 in Review

Alyeska Investment Group sold out of Kazia Therapeutics (KZIA) in Q1 2026, closing a stake of 738,321 shares — an estimated $5.09M sold.

Alyeska Investment Group first reported a position in KZIA in Q4 2025 and held it in 1 quarter. The position peaked at $5.09M in Q4 2025. 23 funds tracked by Wall St. Rank hold KZIA as of Q1 2026.

  • Alyeska Investment Group reported no remaining Kazia Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Alyeska Investment Group sold 738,321 Kazia Therapeutics shares in Q1 2026, an estimated $5.09M.
  • Alyeska Investment Group first reported a position in Kazia Therapeutics in Q4 2025 and held it in 1 quarter.
  • Alyeska Investment Group's Kazia Therapeutics position peaked at $5.09M in Q4 2025.
  • 23 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.